Peter Ross - Publications, H-index & Citations

Peter Ross

Edinburgh Napier University

32H指数

159论文数

4.1K被引数

收录论文 9

发表时间

Assessing nivolumab in class II expressing microsatellite stable (pMMR) colorectal cancer (CRC): Results of the ANICCA-Class II trial

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Middleton, G.; Liu, W.; Savage, J.; Bridgewater, J. A.; Ross, P.; Saunders, M. P.; Plummer, R.; Clive, S.; Coyle, V.; Thomas, A.; Taniere, P.; Billingham, L.

Impact of COVID-19 pandemic on clinical outcomes in hepatocellular carcinoma: A multicentre cohort study

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

De Souza, S.; De Jong, J. Kahol; Jones, R.; Reeves, H.; Shetty, S.; Orr, J.; Bettinger, D.; Yip, V.; Temperley, L.; Geh, D.; Qurashi, M.; Allen, B.; Sturm, L.; Banerjee, A.; Ross, P.; Sharma, R.

Clinical role of tumour markers in advanced biliary cancers (ABC) treated with second-line active-symptom-control (ASC) alone or ASC with oxaliplatin/5-FU chemotherapy (ASC plus mFOLFOX) in the randomised phase III, multi-centre, open-label ABC-06 trial

ANNALS OF ONCOLOGY

IF65.4

2022-06-01

OAAI

Lamarca, A.; Palmer, D.; Wasan, H.; Ross, P.; Ma, Y. Ting; Arora, A.; Falk, S.; Gillmore, R.; Wadsley, J.; Patel, K.; Anthoney, A.; Maraveyas, A.; Waters, J.; Hoobs, C.; Macdonald, T.; Ryder, D.; Ramage, J.; Davies, L.; Bridgewater, J.; Valle, J.

Comparison of resected vs non-resected patients with unresectable locally advanced pancreatic cancer (LAPC) receiving P-32 microparticles with gemcitabine/nabpaclitaxel or FOLFIRINOX chemotherapy in the PanCO study

ANNALS OF ONCOLOGY

IF65.4

2022-06-01

OAAI

Ross, P.; Nikfarjam, M.; Nguyen, N.; Aghmesheh, M.; Burnett, D.; Wasan, H.; Turner, D.; Croagh, D.

A unified hyper-heuristic framework for solving bin packing problems 解决装箱问题的统一超启发式框架

EXPERT SYSTEMS WITH APPLICATIONS

IF7.5

2014-11-01

PREAI

Lopez-Camacho, Eunice; Terashima-Marin, Hugo; Ross, Peter; Ochoa, Gabriela